Should employers & insurers cover psychedelic-assisted therapy?

The latest stories trending on MedCity News.

Editor's Pick

Top Story Should Employers and Insurers Cover Psychedelic-Assisted Therapy? Despite ketamine-assisted therapy being approved for treating several mental health conditions, it's generally not covered by insurance or employers. Though that likely won't always be the case, as psychedelics gather more research and employers notice the benefits for their workplaces. Sponsored How to Leverage Diagnostic Development to Guard Against RSV, Flu and Covid-19 Presented by BD and MedCity News A webinar sponsored by BD scheduled for March 7 will explore the following: How diagnostics companies are working with healthcare organizations to guard against the perfect storm of Covid-19, RSV and influenza. Clinical presentation and symptoms  Impact on children and the pediatric population The BD Veritor™ Plus System and its benefits Innovations that companies such as BD have enacted to support public health Register today!

Featured News

Report: Class-action Securities Lawsuits Decline but Risks Remain for Life-sciences Companies Disgruntled investors lodged fewer securities claims against life-science companies last year. But when they did sue, investors raised familiar issues, often tied to bad news around clinical research and regulatory approvals, according to a law firm report Eli Lilly Places a Small Bet on Confo's Early-Stage, Non-Opioid Pain Drug Eli Lilly is paying $40 million up front for rights to a Confo Therapeutics drug in Phase 1 testing as a potential treatment for neuropathic pain. Confo develops drugs that target G-protein coupled receptors. High-cost Pharmacy Claims, Medical Inflation Among Top Threats for Employers When asked what the biggest threats facing them were, 94% of employers said high-cost pharmacy claims, 91% said medical inflation and 91% said million dollar treatments being approved by the FDA, according to a new survey from the Midwest Business Group on Health. 5 Factors Holding Back Healthcare Practices From Adopting RPM Just a quarter of healthcare practices offer remote patient monitoring, and the majority of them aren't too eager to adopt the technology any time soon, according to a new report. A few factors are influencing this reluctance, including data security concerns, unclear reimbursement policies and training requirements. Abridge Begins the Largest Deployment of Its Medical Documentation AI Abridge announced the largest deployment of its technology to date — the University of Kansas Health System will adopt the software for more than 1,500 of its physicians across 140 locations. The startup's technology listens to visits and creates a near-instant summary that adheres to physicians' prototypical note structure. 'Challenging Market' Leads MorphoSys to Cut Preclinical R&D, Turn Focus to Cancer MorphoSys's emphasis on its clinical-stage cancer programs puts the spotlight on a myelofibrosis drug candidate from its 2021 acquisition of Constellation Pharmaceuticals. That small molecule could compete against drug candidates from GSK and Merck.

Resources

How Top Health Plans Use AI to Save Money and Work Smarter Learn how an AI-powered solution helped Blue Cross Blue Shield of Rhode Island target members within its congestive heart failure (CHF) and spinal care (MSK) programs to identify avoidable hospitalizations and drive significant cost savings.   Download Now

MedCity News • 611 Broadway • New York, NY unsubscribe